1.20 USD
↗ 0.02 (1.44%)LIVE (AS OF 03:21 PM EDT)
Pluri Inc. Common Stock
PLURNASDAQ • USD
Market: OPEN
Shares of Pluri Inc. Common Stock (PLUR) are trading at $1.20. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (113.5%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 11, 2026.
Open?$1.19
High?$1.37
Low?$1.19
Prev. Close?$1.18
Volume?5.4K
Avg. Volume?25.4K
VWAP?$1.25
Rel. Volume?0.21x
Bid / Ask
Bid?$1.02 × 100
Ask?$1.50 × 100
Spread?$0.48
Midpoint?$1.26
Valuation & Ratios
Market Cap?14.6M
Shares Out?12.3M
Float?6.1M
Float %?56.1%
P/E Ratio?N/A
P/B Ratio?-0.69
EPS?-$1.93
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Themes
Employees
142
Market Cap
14.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1991-10-09
Address
MATAM ADVANCED TECHNOLOGY PARK
HAIFA,
Phone: 972-74-710-7171
HAIFA,
Phone: 972-74-710-7171
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?17
Short Sent.?60
Piotroski F-Score?2/9Weak
Altman Z-Score?-30.42Distress
Confidence?54%Low
Short InterestLow
Short % of Float?0.44%Low
Short Interest?26.4K
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume37.9K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.27Weak
Quick Ratio?0.27Weak
Cash Ratio?0.11Low
Debt/Equity?-1.31Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-0.69CHEAP▾
S&P97
P/S?14.34HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?37.86HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?113.5%STRONG▾
Peers50
S&P97
ROA?-95.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-20221000
Enterprise Value?$38.5M
Fundamentals ratios updated end of day